b.value AG

Founded in 2016, b.value AG is a venture capital firm based in Dortmund, Germany. The firm seeks to invest during the seed stage in companies operating in the non-pharmaceutical biotechnology and chemistry sectors in the Germany, Austria, and Switzerland regions. The firm focuses on health and nutrition, resource efficiency, and digitization mega-trends.

Peter Kallien

Founder and Managing Director

Georg Lentzen

Managing Director

Cornelia Bähr Ph.D

Senior Investment Manager

9 past transactions

LOVR

Pre Seed Round in 2022
Our ambition is to lead the necessary radical change in the textile industry. That’s why we have developed a new textile: LOVR. The material looks and feels like leather, is just as robust, but comes without any of its drawbacks: LOVR is 100% free of animal products, plastics, and hazardous chemicals. Even better, because LOVR is based on fibrous residues of hemp cultivation and produced by a process similar to paper making, it is completely biodegradable. Through our innovative, patent-pending production process, LOVR is entirely CO2e-neutral. LOVR is currently manufactured at the lab but production will be scaled up and mechanized. In addition to selling LOVR as yard goods (starting in 2022) the technology will be licensed.

FibreCoat

Venture Round in 2021
FibreCoat GmbH produces thermoplastic-coated glass fibres for use in fibre composites on rented glass fibre drawing machines. Direct coating enables new process steps, lower costs and cycle times while at the same time improving technical specifications. The target markets are the automotive and consumer sectors.

Actome

Seed Round in 2021
Actome specializes in emulsion coupling technology and interactome technology to advance life science research and personalized medicine. The company has developed a proprietary method that allows for the detection of single protein molecules and protein interaction complexes. By translating protein status into DNA barcodes using DNA-labeled antibodies, Actome enables detailed molecular biological research. This innovative approach aids clients in quantifying proteins, analyzing protein interactions, and studying post-translational modifications in biological samples. Through its technologies, Actome contributes to advancements in pharmaceuticals and the development of novel personalized therapies.

Placeme

Seed Round in 2021
Placeme, based in Warsaw, Poland, offers a data-as-a-service application that provides location services tailored for the retail and fast-moving consumer goods sectors. The platform leverages big data and machine learning to predict customer behavior and assess sales potential at specific addresses, thereby assisting businesses in making informed decisions to enhance revenue through improved sales and marketing strategies. By utilizing an easy-to-navigate online tool, users can gain complex insights with minimal effort, such as identifying optimal business locations and understanding consumer habits. Placeme also enables targeted advertising based on geolocation, helping businesses reach potential customers in defined areas. This comprehensive approach allows businesses to analyze customer journeys in both online and offline channels, ultimately facilitating growth and success through strategic location selection.

Traceless

Seed Round in 2021
Provider of advanced materials intended to produce bioplastic film, plastics, and coatings from agriculture residues. The company's technology uses food production residues to produce materials that are compostable under natural composting conditions and provides a marketable product from agricultural residues such as starch or brewery residues as a raw material for home compostable, harmless for the environment and humans, enabling the society to get rid of the plastic materials that lead to serious environmental, marine pollution and lower carbon emissions.

b.fab

Venture Round in 2021
B.fab is a biotechnology company focused on transforming carbon dioxide and hydrogen derived from renewable energy into valuable biotechnological products. Utilizing formate as a key mediator, B.fab converts CO2 and H2 into liquid form for further processing. The company employs synthetic biology to design specific metabolic pathways, enabling the production of value-added chemicals, such as proteins for aquaculture and biopolymer building blocks. With a platform that integrates both anaerobic and aerobic microbial production hosts, B.fab offers flexibility in process design to meet various product specifications. Founded in 2018 in Dortmund, Nordrhein-Westfalen, B.fab leverages laboratory automation, high-throughput experimentation, and advanced bioprocess development to efficiently create new bioprocesses in a rapid and agile manner.

Belano medical

Venture Round in 2020
Operator of a human microbiome research company intended to develop medical and skincare products. The company develops and markets novel therapeutic approaches for medical skin care, for the prevention of diseases, and for supporting healing processes, enabling patients to get new therapy options for diseases and indications that have not been satisfactorily treated to date.

Cellbricks

Venture Round in 2019
Developer of a bio-fabrication platform intended to address the global challenge of organ shortage and the need for improved in-vitro models. The company's platform helps the industrial production of large and complex structures, seamlessly integrating different biomaterials and cell varieties, enabling medical researchers to provide their patients with improved clinical treatments.

SenseUp

Venture Round in 2017
SenseUp is a biotech company that develops microbial production-strains. It offers de-novo construction or optimization of existing strains, using state of the art genomics, transcriptomics, and metabolomics, accompanied by our unique biosensor-technology. It was founded in 2015 and is headquartered in Jülich, North Rhine-Westphalia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.